+Compare
PEN
Stock ticker: NYSE
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
8.92B

PEN Penumbra Forecast, Technical & Fundamental Analysis

a manufacturer of medical devices

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for PEN with price predictions
07:00 PM EST Nov 29, 2023

PEN's RSI Indicator recovers from overbought zone

The 10-day RSI Indicator for PEN moved out of overbought territory on November 21, 2023. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 46 instances where the indicator moved out of the overbought zone. In of the 46 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 61 cases where PEN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on November 30, 2023. You may want to consider selling the stock, shorting the stock, or exploring put options on PEN as a result. In of 77 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PEN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

PEN broke above its upper Bollinger Band on November 13, 2023. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for PEN entered a downward trend on November 15, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for PEN just turned positive on October 31, 2023. Looking at past instances where PEN's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .

PEN moved above its 50-day moving average on November 17, 2023 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for PEN crossed bullishly above the 50-day moving average on November 24, 2023. This indicates that the trend has shifted higher and could be considered a buy signal. In of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PEN advanced for three days, in of 340 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. PEN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock slightly better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.849) is normal, around the industry mean (25.181). P/E Ratio (212.766) is within average values for comparable stocks, (79.548). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (6.249). Dividend Yield (0.000) settles around the average of (0.019) among similar stocks. P/S Ratio (8.780) is also within normal values, averaging (44.232).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Intuitive Surgical (NASDAQ:ISRG), Medtronic plc (NYSE:MDT), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW), IQVIA Holdings (NYSE:IQV), Align Technology (NASDAQ:ALGN), Illumina (NASDAQ:ILMN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 6.4B. The market cap for tickers in the group ranges from 27 to 3.82T. MKYSF holds the highest valuation in this group at 3.82T. The lowest valued company is FOGCF at 27.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was 2%. For the same Industry, the average monthly price growth was 13%, and the average quarterly price growth was 702%. VVOS experienced the highest price growth at 509%, while SHWGF experienced the biggest fall at -44%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was 64%. For the same stocks of the Industry, the average monthly volume growth was 33% and the average quarterly volume growth was 93%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 69
Price Growth Rating: 55
SMR Rating: 84
Profit Risk Rating: 88
Seasonality Score: 18 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Ad is loading...
A.I. Advisor
published Earnings

PEN is expected to report earnings to rise 204.09% to 69 cents per share on February 27

Penumbra PEN Stock Earnings Reports
Q4'23
Est.
$0.70
Q3'23
Missed
by $0.22
Q2'23
Beat
by $0.15
Q1'23
Beat
by $0.12
Q4'22
Beat
by $0.01
The last earnings report on November 02 showed earnings per share of 23 cents, missing the estimate of 44 cents. With 6.20K shares outstanding, the current market capitalization sits at 8.92B.
A.I. Advisor
published General Information

General Information

a manufacturer of medical devices

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
One Penumbra Place
Phone
+1 510 748-3200
Employees
3900
Web
https://www.penumbrainc.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
FIO.X0.0230880.000339
+1.49%
FIO Protocol cryptocurrency
CKB.X0.0031680.000006
+0.20%
Nervos Network cryptocurrency
TRX.X0.103515-0.000029
-0.03%
TRON cryptocurrency
TVK.X0.048781-0.000026
-0.05%
Virtua cryptocurrency
ILV.X107.740970-1.594452
-1.46%
Illuvium cryptocurrency

PEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, PEN has been loosely correlated with RVTY. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if PEN jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PEN
1D Price
Change %
PEN100%
-1.99%
RVTY - PEN
49%
Loosely correlated
-0.57%
DXCM - PEN
48%
Loosely correlated
-0.57%
INSP - PEN
48%
Loosely correlated
+0.73%
BSX - PEN
47%
Loosely correlated
+0.81%
ISRG - PEN
46%
Loosely correlated
+0.03%
More

Groups containing PEN

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PEN
1D Price
Change %
PEN100%
-1.99%
medical research
(undefined stocks)
56%
Loosely correlated
+0.19%
medical service
(undefined stocks)
52%
Loosely correlated
+0.18%
Medical Specialties
(undefined stocks)
48%
Loosely correlated
-0.01%
Medical Specialties
(undefined stocks)
48%
Loosely correlated
-0.01%
medical devices
(undefined stocks)
44%
Loosely correlated
+0.64%